The early-stage venture capital-backed company focuses on enhancing the clinical performance of endovascular prostheses, with an immediate focus on treating abdominal aortic aneurysms (AAAs). By combining mechanical engineering and polymer science, the company's medical technology platform helps doctors perform surgical procedures more efficiently. While the technology has potential applications for a range of vascular disease states, Endoluminal Sciences is committed to improving the treatment of AAAs.